Teva Gets Positive CHMP Opinion For DuoResp Spiromax To Treat Asthma And … – RTT News

Teva Gets Positive CHMP Opinion For DuoResp Spiromax To Treat Asthma And
RTT News
DuoResp Spiromax is a new multi-dose dry-powder inhaler with a combination of budesonide, an inhaled corticosteroid to treat the underlying inflammation in asthma and COPD, and formoterol fumarate dihydrate, a rapid-acting and long-lasting beta2 
EU Agency backs respiratory drugs for approvalReuters UK
EMA Backs Generic Versions of AstraZeneca's SymbicortBloomberg

all 7 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.